Ultrasound Guided Sciatic Nerve Block

Completed · Not applicable

Conditions studied: Sciatic Nerve

In brief

The primary purpose of this study is to determine whether the leg positioning or distal tourniquet used during the injection of local anesthetic may decrease the onset time and prolong the duration of analgesia of ultrasound-guided Sciatic Nerve Block (SNB) with popliteal approach. Patients will be divided randomly into three groups: group 1 will receive sciatic nerve block, with leg kept in a neutral position after anesthesia (control group); group 2 will receive the same anesthesia, with leg raised 30° by placing the back of the foot over a support placed on the OR table and maintained in that position for 15 min; and patients in group 3 will receive the same anesthesia, and distal tourniquet placed on the lower part of the leg (upper part of the tourniquet being about 4-6 inches from the ankle) with the leg in a neutral position

Key facts

Study ID

NCT02688439

Run by

NYU Langone Health

People needed

81

Starts

2015-03-01

Expected to finish

2019-07-10

Last updated by the study team

2019-08-05

Who can join

Age: 21 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing elective foot surgery under ultrasound guided popliteal sciatic/saphenous block
• American Society of Anesthesiologist physical status 1-3, meaning patients who are either completely or their systemic disease(s), if they have is (are) under control with medications or other means.
• Have capacity to provide informed consent.

You may not qualify if…

• clinically significant coagulopathy (impaired blood clotting)
• infection at injection site
• allergy to local anesthetics
• severe cardiopulmonary disease (heart and lung disease)
• body mass index >35 kg.m2
• known neuropathies (degenerative, infectious and traumatic peripheral nerve diseases)
• who are receiving opioids for chronic analgesic therapy at the time of contemplated surgery
• Patients with history of AIDS, tuberculosis, and other infections
• active and/or unstable cardiac, renal, pulmonary and neurologic disorders will be excluded from the study. This includes patients in heart failure having limited exercise ability, end stage renal failure on dialysis treatment, recent stroke etc.
• Vulnerable subjects (children, pregnant subjects, prisoners, mentally impaired) also will not be included in the study.
• Subjects who do not understand or speak English

Where it is running

• New York University School of Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.